Gee-Chen Chang

10PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsHaematological tumoursEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 01, 2024
Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer.

Wei-Fan Ou, Kuo-Hsuan Hsu, Jeng-Sen Tseng

|Oct 11, 2024
Taiwan Nationwide Study of First-Line ALK-TKI Therapy in ALK-Positive Lung Adenocarcinoma.

Zhe-Rong Zheng, Jia-Jun Wu, Chun-Ju Chiang

|Jul 13, 2024
Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination.

Po-Hsin Lee, Wei-Fan Ou, Yen-Hsiang Huang

|Jan 08, 2024
Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib.

Jia-Jun Wu, Jeng-Sen Tseng, Zhe-Rong Zheng

|Jan 08, 2023
Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment.

Po-Hsin Lee, Yen-Hsiang Huang, Yu-Wei Hsu

|Sep 21, 2022
Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan.

Li-Hsin Chien, Tzu-Yu Chen, Chung-Hsing Chen

Pageof 2

Frequent Collaborators

5 joint publications

Jia-Jun Wu

3 joint publications

Kuo-Hsuan Hsu

3 joint publications

Tsung-Ying Yang

2 joint publications

Pan-Chyr Yang